Disease/Infection News

RSS

Customs Organization to sign declaration against counterfeit drugs

The World Customs Organization will sign a declaration to fight the $200-billion-a-year counterfeit drug industry, Reuters reports.

14 Jun 2010

AIDS/LifeCycle event raises $10M to support HIV/AIDS services

More than 2,400 participants in AIDS/LifeCycle arrived at the Veterans Center in Los Angeles today after traveling 545 miles from San Francisco over the past seven days in the world's largest annual HIV/AIDS fundraising event. In its ninth year, the event raised $10 million to support the services of San Francisco AIDS Foundation and the L.A. Gay & Lesbian Center that prevent new HIV infections and care for those living with HIV/AIDS.

14 Jun 2010

BIOTECanada congratulates CPHA on 100 years of leadership in public health

As a community partner of the Canadian Public Health Association, BIOTECanada, on behalf of Canada's biotechnology industry, congratulates the CPHA on 100 years of leadership in public health.

11 Jun 2010

Community-based model of DOT improves HIV patient survival: Researchers

When applied to HIV care, the community-based model of directly observed therapy has no effect on virologic outcomes, but significantly improves patient survival. This is according to researchers at the Johns Hopkins Bloomberg School of Public Health, in collaboration with colleagues at University of Cape Town, South Africa, who conducted the first randomized controlled trial of patient-nominated treatment-supporters providing partial DOT in resource-limited settings.

11 Jun 2010

Ambulatory Surgery Center industry responds to infection control concerns raised in JAMA

As leading organizations representing the Ambulatory Surgery Center (ASC) industry, we wish to address concerns raised in this month's issue of the Journal of the American Medical Association (JAMA) highlighting data from a 2008 Centers for Medicare and Medicaid Services (CMS) pilot study. The industry underscores its strong commitment to patient safety and its nationwide efforts to provide high-quality, patient-centered care at a low cost to the health care system.

11 Jun 2010

Researchers to present advanced treatment strategies for eye diseases at NEI symposium

The National Eye Institute (NEI), part of the National Institutes of Health (NIH), is bringing together premier researchers who translate molecular and genetic approaches from the laboratory to visual system diseases in the clinic.

11 Jun 2010

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

At a meeting which ended last night, the Executive Board of UNITAID approved a plan to step up efforts to enlist more countries to apply a solidarity levy on air tickets to provide additional funding for the health Millennium Development Goals. The Board approved a number of resolutions, among them the final phase of the establishment of a medicines patent pool, but a situation of depleting funds raises concerns for the many patients currently being treated by UNITAID.

11 Jun 2010

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.

11 Jun 2010

VA selects IRIS to provide communication system for notifying federal employees on H1N1 vaccinations

The U.S. Department of Veterans Affairs has selected TechRadium's IRIS to provide a cloud-computing-based, interoperable communications system for notifying key federal employees of when H1N1 vaccinations are available for them.

11 Jun 2010

Researchers to provide real-time analyses on potential disease threats during World Cup

Two Canadian researchers will be keeping a close eye on what hundreds of thousands of soccer fans take to the World Cup in South Africa _ and what they potentially bring home.

11 Jun 2010

New methodology may help control influenza

Scientists have uncovered the flu's secret formula for effectively evolving within and between host species: balance. The key lies with the flu's unique replication process, which has evolved to produce enough mutations for the virus to spread and adapt to its host environment, but not so many that unwanted genomic mutations lead to the flu's demise (catastrophic mutagenesis).

11 Jun 2010

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

The World Health Organization (WHO), in consultation with the government of the United Kingdom, has designated the Liverpool School of Tropical Medicine (LSTM) as a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases.

11 Jun 2010

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.

11 Jun 2010

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

The draft conclusions for the U.N.'s Millennium Development Goals (MDGs) summit in September, which were distributed to governments last week, call on world leaders to follow through on promises of aid money to help countries reach the benchmarks established in 2000, Reuters reports.

11 Jun 2010

WHO Director-General responds to criticisms over agency's H1N1 response

WHO Director-General Margaret Chan on Tuesday rejected recent criticisms that her decisions to declare H1N1 (swine flu) a pandemic were impacted by her advisers' link to the pharmaceutical industry, the Associated Press reports.

11 Jun 2010

Report urges Canada to increase foreign aid spending for G8 maternal, child health initiative

The coalition Make Poverty History released a report on Wednesday, which praises Canada's spending on food aid and programs aimed at fighting diseases such as HIV/AIDS, tuberculosis and malaria, but it also says Canada should spend more on its maternal and child health G8 initiative, the Canadian Press/CTV News reports.

11 Jun 2010

CPL Biologicals completes construction of vaccine facility in Dholka, India

CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc., today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.

10 Jun 2010

Idenix initiates IDX320 proof-of-concept study for HCV infection

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has initiated a 3-day proof-of-concept study of IDX320, a protease inhibitor for the treatment of hepatitis C virus (HCV) infection, under a Clinical Trial Application (CTA). The study is evaluating IDX320 in treatment-naive hepatitis C genotype 1-infected patients.

10 Jun 2010

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Most of the time, the body's blood-forming (hematopoietic) stem cells remain dormant, with just a few producing blood cells and maintaining a balance among the different types.

10 Jun 2010

Misinterpretation of genetic information may undermine efforts to promote behavioral changes for disease prevention

Does knowing that genes are partly responsible for your health condition mean you are less likely to be motivated to find out about the benefits of behavioral changes? According to Dr. Suzanne O'Neill from the National Human Genome Research Institute/National Institutes of Health, and her colleagues, people on the whole are still interested in how health habits affect disease risk.

10 Jun 2010

Disease/Infection News

Customs Organization to sign declaration against counterfeit drugs

AIDS/LifeCycle event raises $10M to support HIV/AIDS services

BIOTECanada congratulates CPHA on 100 years of leadership in public health

Community-based model of DOT improves HIV patient survival: Researchers

Ambulatory Surgery Center industry responds to infection control concerns raised in JAMA

Researchers to present advanced treatment strategies for eye diseases at NEI symposium

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

VA selects IRIS to provide communication system for notifying federal employees on H1N1 vaccinations

Researchers to provide real-time analyses on potential disease threats during World Cup

New methodology may help control influenza

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

WHO Director-General responds to criticisms over agency's H1N1 response

Report urges Canada to increase foreign aid spending for G8 maternal, child health initiative

CPL Biologicals completes construction of vaccine facility in Dholka, India

Idenix initiates IDX320 proof-of-concept study for HCV infection

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Misinterpretation of genetic information may undermine efforts to promote behavioral changes for disease prevention

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News